Janet Dillione, Director at CorMedix Inc. (CRMD), bought 21,231 shares at $0.48 ($10K) on 2017-05-15, disclosed to the SEC on 2017-05-17.
Open-market purchase of $10k CRMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| CRMD | SELL | 2025-12-04 | $467K | — | Filing → |
| CRMD | SELL | 2025-11-26 | $523K | — | Filing → |
| CRMD | SELL | 2025-11-18 | $343K | — | Filing → |